Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs3
Gocovri
Adamas Pharmaceuticals, Inc.
Felbamate
Taro Pharmaceuticals U.S.A., Inc.
Apokyn
MDD US Operations, LLC
Apokyn
(Apomorphine HCl)Orphan drugstandardMDD US Operations, LLC
Gocovri
(Amantadine hydrochloride)Orphan drugstandardAdamas Pharmaceuticals, Inc.
Influenza A M2 Protein Inhibitor [EPC]
12.1 Mechanism of Action The mechanism by which amantadine exerts efficacy in the treatment of dyskinesia in patients with Parkinson's disease or as a...
Felbamate
(FELBAMATE)Orphan drugstandardTaro Pharmaceuticals U.S.A., Inc.
Anti-epileptic Agent [EPC]
Mechanism of Action The mechanism by which felbamate exerts its anticonvulsant activity is unknown, but in animal test systems designed to detect anti...
Remicade
(infliximab)Orphan drugstandardJanssen Biotech, Inc.
Tumor Necrosis Factor Blocker [EPC]
12.1 Mechanism of Action Infliximab neutralizes the biological activity of TNFα by binding with high affinity to the soluble and transmembrane forms o...